Sintokamide A (SINT1), a small peptide isolated from the marine sponge Dysidea species, has been shown to selectively suppress AR activity in LNCaP prostate cancer cells by inhibiting transactivation of the AR NTD, specifically targeting the AF-1 region. This evidence concerns the gene AR and prostate carcinoma.